Development of a Multi-Institutional Prediction Model for Three-Year Survival Status in Patients with Uterine Leiomyosarcoma (AGOG11-022/QCGC1302 Study).
Ka-Yu TseRichard Wing-Cheuk WongAngel ChaoShir-Hwa UengLan-Yan YangMargaret CummingsDeborah SmithChiung-Ru LaiHei-Yu LauMing-Shyen YenAnnie Nga-Yin CheungCharlotte Ka-Lun LeungKit-Sheung ChanAlice Ngot-Htain ChanWai-Hon LiCarmen Ka-Man ChoiWai-Mei PongHoi-Fong HuiJudy Ying-Wah YukHung YaoNancy Wah-Fun YuenAndreas ObermairChyong-Huey LaiPhilip Pun-Ching IpHextan Yuen-Sheung NganPublished in: Cancers (2021)
We developed a prediction model for uLMS based on five readily available clinicopathologic parameters. This might provide a personalized prediction of the 3-year survival status and guide the use of adjuvant therapy, a cancer surveillance program, and future studies.